Prof. Dr. Frank Gansauge, with over 20 years of expertise in oncology and immunotherapy, is a pivotal figure in delivering personalized dendritic cell vaccine therapies in Germany.
Dendritic cell therapy is an advanced immunotherapy that utilizes dendritic cells, the immune system’s antigen-presenting cells, to stimulate a targeted immune response against colon cancer.
The HER2 protein drives tumor growth, making it a key target for targeted therapies for HER2 positive gastric cancer
Stage 4 stomach cancer, or metastatic gastric cancer, occurs when cancer cells spread beyond the stomach to distant organs such as the liver, lungs, or peritoneum, making treatment more complex
Colon cancer, a malignancy of the large intestine, is staged using the TNM system (Tumor, Node, Metastasis) to describe tumor size, lymph node involvement, and metastasis.
The latest stage 4 colon cancer treatment options in 2025 integrate advanced surgical techniques, systemic therapies, and experimental approaches, tailored to tumor biology and patient health.
Stage 4 rectal cancer is an advanced malignancy where cancer spreads from the rectum to distant organs such as the liver, lungs, bones, or peritoneum.
Stage 4 gastric cancer is an advanced malignancy where cancer has spread from the stomach to distant organs such as the liver, lungs, lymph nodes, or peritoneum.
Offering a spectrum of therapies, including minimally invasive stomach cancer surgery, chemotherapy, and innovative approaches like dendritic cell therapy, these centers provide hope for patients at all stages.
Cervical cancer develops in the cells of the cervix, the lower part of the uterus connecting to the vagina, often linked to persistent human papillomavirus (HPV) infection.
This blog explores which treatments are available for endometrial cancer, highlighting the role of can we use dendritic cell therapy? in achieving optimal outcomes.
Dendritic cell therapy is a personalized immunotherapy that uses a patient’s own dendritic cells key immune system components to stimulate a targeted immune response against cancer cells.
Colorectal cancer (CRC) is a leading global malignancy, with up to 25% of patients developing metastatic colorectal cancer liver, known as CRLM.
Ovarian cancer, originating in the ovaries, and cervical cancer, often linked to Human Papillomavirus (HPV) infection in the cervix, are significant health challenges for women worldwide
